Drug intelligence / Profile preview

frusemide + indomethacin

Development stage
Unknown
Modality
Small Molecules
Administration
Oral, Intravenous, Intramuscular, Rectal
01

Overview

This is a combination of two small molecule drugs, frusemide (also known as furosemide) and indomethacin. Frusemide is a loop diuretic that inhibits the sodium-potassium-chloride cotransporter in the thick ascending limb of the loop of Henle, leading to increased excretion of sodium, chloride, and water. Indomethacin is a nonsteroidal anti-inflammatory drug (NSAID) that inhibits cyclooxygenase enzymes (COX-1 and COX-2), reducing prostaglandin synthesis and exerting anti-inflammatory, analgesic, and antipyretic effects. When used together, indomethacin can blunt or reduce the natriuretic (sodium-excreting) and antihypertensive effects of frusemide by inhibiting renal prostaglandin synthesis[1][2][6]. This interaction may be clinically significant in conditions such as heart failure or when both drugs are required for specific indications like patent ductus arteriosus closure in neonates[1][3].

02

Targets

PGHS-1 (Prostaglandin G/H Synthase 1)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)NKCC (Sodium-potassium-chloride cotransporter)

Beyond the preview

Go deeper on frusemide + indomethacin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on frusemide + indomethacin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call